400-93-1

Basic information

• Product Name: 4'-Fluoro-3'-nitroacetophenone
• Synonyms: 4'-Fluoro-3'-nitroacetophenone,98%;1-(4-Fluoro-3-nitrophenyl)ethan-1-one;1-(4-Fluoro-3-nitrophenyl)ethan-1-one, 5-Acetyl-2-fluoronitrobenzene;4-Fluoro-3-nitroacetophneone;4′-Fluor-3′-nitroacetophenon;4'-Fluoro-3'-notroacetophenone;Ethanone, 1-(4-fluoro-3-nitrophenyl)-;1-(4-FLUORO-3-NITRO-PHENYL)-ETHANONE
• CAS NO: 400-93-1
• Molecular Formula: C₈H₆FNO₃
• Molecular Weight: 183.14
• EINECS: -0
• Product Categories: Carbonyl Compounds;Ketones;Acetophenone series;ketone;Miscellaneous;C7 to C8
• Mol File: 400-93-1.mol

Chemical Properties

• Melting Point: 46-50 °C
• Boiling Point: 118-120°C 0,8mm
• Flash Point: 118-120°C/0.8mm
• Appearance: Light yellow/Crystalline Powder
• Density: 1.336 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• BRN: 2211976
• CAS DataBase Reference: 4'-Fluoro-3'-nitroacetophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-Fluoro-3'-nitroacetophenone(400-93-1)
• EPA Substance Registry System: 4'-Fluoro-3'-nitroacetophenone(400-93-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 37/39-26
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 400-93-1(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
4'-Fluoro-3'-nitroacetophenone is used as a reactant/reagent for the preparation of substituted furans via copper-catalyzed radical addition of acetophenones to alkynes. This application takes advantage of its chemical properties to facilitate the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4'-Fluoro-3'-nitroacetophenone is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Material Science:
4'-Fluoro-3'-nitroacetophenone can also be utilized in the field of material science, where it may contribute to the development of novel materials with specific properties, such as improved stability or reactivity.
Used in Research and Development:
Due to its unique chemical structure, 4'-Fluoro-3'-nitroacetophenone is valuable in research and development settings, where it can be used to explore new reaction pathways and develop innovative synthetic methods.

Upstream product

• 403-42-9 1-(4-fluorophenyl)ethanone 

Downstream Products

• 93716-97-3 3-Nitro-4-<4-chlor-phenoxy>-acetophenon 
• 92856-56-9 3-Nitro-4-<4-methoxycarbonyl-phenoxy>-acetophenon 
• 31477-38-0 <2-Nitro-4-acetyl-phenyl>-β-naphthylaether 
• 31477-27-7 3-Nitro-4-<2-nitro-phenoxy>-acetophenon 
• 2002-82-6 1-(3-amino-4-fluorophenyl)ethanone 
• 67500-19-0 5'-Amino-2'-fluoroacetophenone 
• 206878-19-5 5-Acetyl-1-(3-(1-methyl-1,2,3,6-tetrahydropyrid-5-yl)phenyl)benzimidazole O-ethyl oxime 
• 2105-96-6 4-fluoro-3-nitrophenol 
• 874984-58-4 1-[4-(5-ethyl-2,4-dimethoxy-phenylamino)-3-nitro-phenyl]-ethanone 
• 19688-48-3 3-nitro-4-(2-methoxythiophenoxy)-acetophenone 
• 1055988-24-3 C₁₈H₁₉N₃O₃ 
• 773858-91-6 4-acetyl-2-nitro-N-(3-(3-isoxazolyl)phenyl)aniline 
• 184098-07-5 1-[4-(3-bromo-phenylamino)-3-nitro-phenyl]-ethanone 
• 477312-57-5 4-[5-(1-azido-ethyl)-2-fluoro-phenyl]-morpholine 

Relevant articles and documents

Profiling the interaction of a novel toxic pyruvate dehydrogenase kinase inhibitor with human serum albumin

To discover novel pyruvate dehydrogenase kinase (PDK) inhibitors, a new compound 2,2-dichloro-1-(4-((4-isopropylphenyl)amino)-3-nitrophenyl)ethan-1-one, namely XB-1 was identified, which inhibited PDK activity with a half maximal inhibitory concentration

Photoinduced Iron-Catalyzed ipso-Nitration of Aryl Halides via Single-Electron Transfer

A photoinduced iron-catalyzed ipso-nitration of aryl halides with KNO2 has been developed, in which aryl iodides, bromides, and some of aryl chlorides are feasible. The mechanism investigations show that the in situ formed iron complex by FeSO4, KNO2, and 1,10-phenanthroline acts as the light-harvesting photocatalyst with a longer lifetime of the excited state, and the reaction undergoes a photoinduced single-electron transfer (SET) process. This work represents an example for the photoinduced iron-catalyzed Ullmann-type couplings.

Semicarbazone compounds and application thereof

The invention belongs to the technical field of medicines, and relates to semicarbazone compounds as shown in a general formula I and pharmaceutically acceptable salts, hydrates or prodrugs thereof, wherein the definitions of substituent groups R1, R2, R3

Design, synthesis and biological evaluation of novel aryl-acrylic derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors

Two series of novel aryl-acrylic derivatives were designed, synthesized, and screened in enzymatic and cellular inhibitory activities. All compounds showed moderate to significant potency. The SAR analyses indicated that the semicarbazone linker is better

Thiazole derivative compounds having IDO inhibitory activity, preparation method and application thereof

The invention relates to the technical field of medicinal chemistry, in particular to thiazole derivative compounds having IDO (indoleamine-2,3-dioxygenase) inhibitory activity, a preparation method and application thereof. The invention discloses thiazol

Dichloroacetophenones targeting at pyruvate dehydrogenase kinase 1 with improved selectivity and antiproliferative activity: Synthesis and structure-activity relationships

Dichloroacetophenone is a pyruvate dehydrogenase kinase 1 (PDK1) inhibitor with suboptimal kinase selectivity. Herein, we report the synthesis and biological evaluation of a series of novel dichloroacetophenones. Structure-activity relationship analyses (SARs) enabled us to identify three potent compounds, namely 54, 55, and 64, which inhibited PDK1 function, activated pyruvate dehydrogenase complex, and reduced the proliferation of NCI-H1975 cells. Mitochondrial bioenergetics assay suggested that 54, 55, and 64 enhanced the oxidative phosphorylation in cancer cells, which might contribute to the observed anti-proliferation effects. Collectively, these results suggested that 54, 55, and 64 could be promising compounds for the development of potent PDK1 inhibitors.

IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS

A series of 2-imino-6-methyltetrahydropyrimidin-4(lH)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.

PHOSPHODIESTERASE 10 INHIBITORS

The present invention if directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and processes for preparing such compounds. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

Synthesis of fluorinated 1-(3-Morpholin-4-yl-phenyl)-ethylamines

The synthesis of four (±)-fluorinated 1-(3-morpholin-4-yl-phenyl)-ethylamines and an enantioselective approach to these amines through reductive amination are described.

PROCESS FOR PRODUCING 4-SUBSTITUTED-2-NITRO-FLUOROBENZENES

A process for selectively eliminating a compound of general formula (II) from a mixture of a compound of general formula (I) with the compound of general formula (II). This process comprises reacting the compound of general formula (II) with a tertiary am